Owens & Minor (NYSE:OMI) Issues Earnings Results

by · The Cerbat Gem

Owens & Minor (NYSE:OMI – Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.42 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01, Briefing.com reports. The company had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period last year, the company earned $0.44 earnings per share. Owens & Minor updated its FY 2024 guidance to 1.450-1.550 EPS and its FY24 guidance to $1.45-1.55 EPS.

Owens & Minor Trading Down 1.8 %

NYSE:OMI opened at $11.78 on Wednesday. The stock has a fifty day simple moving average of $14.54 and a 200 day simple moving average of $16.19. The firm has a market capitalization of $908.24 million, a price-to-earnings ratio of -21.04, a price-to-earnings-growth ratio of 0.43 and a beta of 0.41. Owens & Minor has a 1-year low of $11.42 and a 1-year high of $28.35. The company has a quick ratio of 0.51, a current ratio of 1.09 and a debt-to-equity ratio of 2.17.

Wall Street Analyst Weigh In

OMI has been the topic of a number of recent analyst reports. Citigroup dropped their price target on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday. UBS Group cut their target price on Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday. JPMorgan Chase & Co. lowered their price target on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating on the stock in a research report on Wednesday, August 21st. Barclays cut their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday. Finally, Robert W. Baird lowered their target price on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a report on Tuesday. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $18.50.

View Our Latest Report on OMI

About Owens & Minor

(Get Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Featured Stories